Acsel Health, an OPEN Health Company
Written on Tuesday 6th June 2023
Following a lively conference in Nashville earlier this year, the Medical Affairs Professional Society (MAPS) continued the dialogue with delegates from the EMEA region in Lisbon, again focusing on the theme “Expanding the Horizons of Medical Affairs.” The OPEN Health team participated in the conference, leading four workshops in partnership with key members of the Medical Affairs community.
Topics discussed during the conference sessions included patient centricity, artificial intelligence, real-world evidence, omnichannel, cross-functional collaboration, and more. Over two parts, our experts summarize their key findings.
Industry trends driving decision-making in Medical Affairs, by Karen King, OPEN Health EVP, and Mark Wheeler, OPEN Health Senior Strategic Planner
At the congress, Karen King and Mark Wheeler ran a session alongside industry partners, with a view to:
Patient centricity, real-world evidence generation & integrated evidence, omnichannel and personalized engagement and new technology and AI applications are the trends most cited in various industry publications, as well as voted on by session participants. Interestingly, strategic leadership and the changing role of the medical science liaison (MSL) were also highlighted as an important trend. The workshop session used Gartner hype cycles as a framework to represent the maturity, adoption, and social application of specific technologies, where appropriate. Input from attendees was used to build hype cycles to analyze the status of industry trends across the audience.
Artificial intelligence (AI) was very much a hot topic at this conference, and companies already integrating AI into customer relationship management (CRM) models are demonstrating the practical applications, such as to help with customer understanding and to suggest the “next best action” for an MSL. Most organizations are exploring AI, with varying degrees of commitment and success. It was generally acknowledged that ChatGPT and similar large language tools are very much “noise,” and further exploration of the technology and a fundamental compliance overhaul will be required to take real advantage of them.
In general, most workshop participants felt that their organizations were in the early days of adopting AI; however, some felt that they were already starting to see its utility behind the scenes in relation to CRM and customer understanding.
The real-world evidence (RWE) landscape is changing, with increasing regulatory requirements around RWE generation and greater use of data analytics, allowing multiple datasets to be combined and faster data collection from electronic medical records. The future sees MSLs armed with the scientific acumen to have robust conversations on RWE with the payer audience, with clear alignment between market access and medical teams.
However, it is clear that a lot of work still must be done in this area before it is optimized. Delegates commented that having a central view and governance was critical across a company, and training on key skills such as understanding different methodologies, interpreting RWE data, and storytelling was important across Medical Affairs teams and functions. Having agreement from senior management on priorities and processes and systems in place to optimize cross-functional teams working in this area was a core focus for next actions to implement this trend within pharmaceutical organizations.
What 3 next actions would you prioritize to implement this trend in your organization?Summary from workshop
While omnichannel remains of huge interest and relevance in Medical Affairs, strategic leadership in this area is still developing. Clear alignment between omnichannel goals and leveraging cross-functional experiences are required for success. The capture, analysis, review, and interpretation of medical insights from all sources, and linking the key findings back into the medical strategy, were identified as equally critical steps.
Another challenge raised was how teams can best ensure that the content they develop reaches healthcare professionals (HCPs). Many companies are investing in comprehensive portals of information to provide a one-stop shop for HCPs but often struggle with how best to personalize content to ensure that messages resonate at an individual level. Overall, it was agreed that there is a significant mindset change still required to bring Medical Affairs along the omnichannel journey.
Although some felt that patient centricity was still something spoken about but not fully embraced in their organizations, many participants believed patient centricity was finally becoming a more real, tangible part of their business. Factors linked strongly to this were the level of insight now being generated on understanding patient needs and translating these insights through to more robust RWE generation.
Cross-functional collaboration: Medical Affairs providing strategic leadership, by Emma Winter, OPEN Health SVP Medical and Scientific Services
During the conference discussions, it was acknowledged that cross-functional collaboration between medical and commercial teams still needs further optimization. There is a need to better quantify and communicate the value that Medical Affairs teams provide as the third pillar between clinical development and commercial, because they bring unique insights on the needs of payers, patients, and HCPs. Medical Affairs co-leading at the pre-approval stage was considered to be critical, as this can impact brand strategy, and colleagues were encouraged to step up and be present early on in the clinical development pathway to ensure that the right decision-making happens.
Medical Affairs is clearly on an exciting journey of leadership and innovation. OPEN Health leverages our scientific acumen and multidisciplinary expertise to:
If you want to know more about how OPEN Health can help you to navigate these emerging trends, please contact us.